Finally, we show that endothelial c-Maf protects from liver fibrosis by controlling LSEC chromatin accessibility, promoting hepatic sinusoidal endothelial vs. continuous endothelial identity and suppressing activation of profibrotic and angiogenic endothelial gene programs in the liver. The gene discussed is MAF; the disease is Hepatic fibrosis.